These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36226601)

  • 1. Spatial dependence modeling of latent susceptibility and time to joint damage in psoriatic arthritis.
    Mao F; Cook RJ
    Biometrics; 2023 Sep; 79(3):2605-2618. PubMed ID: 36226601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite likelihood for joint analysis of multiple multistate processes via copulas.
    Diao L; Cook RJ
    Biostatistics; 2014 Oct; 15(4):690-705. PubMed ID: 24719283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented composite likelihood for copula modeling in family studies under biased sampling.
    Zhong Y; Cook RJ
    Biostatistics; 2016 Jul; 17(3):437-52. PubMed ID: 26819481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixture distributions in multi-state modelling: some considerations in a study of psoriatic arthritis.
    O'Keeffe AG; Tom BD; Farewell VT
    Stat Med; 2013 Feb; 32(4):600-19. PubMed ID: 22833400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis.
    Cresswell L; Chandran V; Farewell VT; Gladman DD
    Ann Rheum Dis; 2011 Feb; 70(2):305-8. PubMed ID: 20980703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The illness-death model for family studies.
    Lee J; Cook RJ
    Biostatistics; 2021 Jul; 22(3):482-503. PubMed ID: 31742352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Score tests based on a finite mixture model of Markov processes under intermittent observation.
    Jiang S; Cook RJ
    Stat Med; 2019 Jul; 38(16):3013-3025. PubMed ID: 30972787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model.
    Helliwell PS; Hetthen J; Sokoll K; Green M; Marchesoni A; Lubrano E; Veale D; Emery P
    Arthritis Rheum; 2000 Apr; 43(4):865-71. PubMed ID: 10765932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of peripheral joint involvement in psoriatic arthritis-Symmetric, ray and/or row?
    Chandran V; Stecher L; Farewell V; Gladman DD
    Semin Arthritis Rheum; 2018 Dec; 48(3):430-435. PubMed ID: 29724452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy. A new tool to differentiate psoriatic from rheumatoid arthritis.
    Ezziddin S; Khalaf F; Seidel M; Al Zreiqat A; Wilsmann-Theis D; Simon B; Biersack HJ; Sabet A
    Nuklearmedizin; 2015; 54(4):183-9. PubMed ID: 25864944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey.
    Radtke MA; Reich K; Blome C; Rustenbach S; Augustin M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):683-91. PubMed ID: 19309433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the heritability and parent-of-origin hypotheses for ages at onset of psoriatic arthritis under biased sampling.
    Lakhal-Chaieb L; Cook RJ; Zhong Y
    Biometrics; 2020 Mar; 76(1):293-303. PubMed ID: 31424087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of secondary failure time responses in studies with response-dependent sampling schemes.
    Zhong Y; Cook RJ; Yu A
    Stat Med; 2023 Nov; 42(26):4763-4775. PubMed ID: 37643587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of interval-censored disease progression data via multi-state models under a nonignorable inspection process.
    Chen B; Yi GY; Cook RJ
    Stat Med; 2010 May; 29(11):1175-89. PubMed ID: 20437455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriatic nail involvement and its relationship with distal interphalangeal joint disease.
    Lai TL; Pang HT; Cheuk YY; Yip ML
    Clin Rheumatol; 2016 Aug; 35(8):2031-2037. PubMed ID: 27251673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial.
    Mease P; Husni ME; Kafka S; Chakravarty SD; Harrison DD; Lo KH; Xu S; Hsia EC; Kavanaugh A
    Arthritis Res Ther; 2020 Mar; 22(1):43. PubMed ID: 32143685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis.
    Skornicki M; Prince P; Suruki R; Lee E; Louder A
    Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic.
    Garg N; Truong B; Ku JH; Devere TS; Ehst BD; Blauvelt A; Deodhar AA
    Clin Rheumatol; 2015 Oct; 34(10):1745-51. PubMed ID: 24827874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of drug effect in radiographic progression for rheumatoid arthritis and psoriatic arthritis.
    Dong B; Lu J
    Pharm Stat; 2019 Jul; 18(4):447-458. PubMed ID: 30806483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for radiological damage in psoriatic arthritis: results from a single centre.
    Bond SJ; Farewell VT; Schentag CT; Gladman DD
    Ann Rheum Dis; 2007 Mar; 66(3):370-6. PubMed ID: 16916855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.